News

The MMRF, in collaboration with the U.S. Food and Drug Administration (FDA), the National Cancer Institute (NCI), pharmaceutical, biotech and diagnostic industry members, academic center leaders and patients,

Under the terms of the agreement, Invetech will provide Argos with services, technology and equipment to support the design, development, supply and maintenance of customized manufacturing systems to

CARBAVANCEis a combination of the carbapenem antibiotic, meropenem, combined with RPX7009, the first of a novel class of beta-lactamase inhibitors. Beta-lactamase inhibitors are agents that inhibit bacterial enzymes,

BL-7010 was found to be safe and well tolerated in both single- and repeated-dose administrations, and the optimal safe dose for future development was determined. Over the next

Mepolizumab is delivered in a 100mg dose via subcutaneous injection every four weeks. Eosinophilic asthma is identified by a blood eosinophil count of at least 150 cells per

ADXS31-142 is the company’s lead Lm-LLO immunotherapy designed to specifically target prostate-specific antigen (PSA). Following FDA’s acceptance of the IND submission, the proposed Phase I/II protocol will assess

The approval of this combination regimen is for patients whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy. The FDA approval is based on data

The new 92-bed treatment facility will be jointly operated by the UK’s Department for International Development (DfID) and charity organisation, Save the Children. The centre includes an 80-bed

The Office of Generic Drugs, U.S. Food and Drug Administration, has determined the Ranbaxy formulations to be bioequivalent and have the same therapeutic effect as that of the